Keep up-to-date with us

Volv Global Insights

All our latest stories, news and insights, including articles and white papers, as well as events, such as webinars and .conferences … and more!

All

Case Studies

Challenges

Clinical Development

Commercial Excellence

Diseases

Earlier Detection

Events

Finding Patients

Guest Article

Insights

Liver Disease

Medical Affairs

News

Oncology

Predicting patient outcomes

Services

Stakeholder

Stratifying patient cohorts

Value & Access HEOR

The Patient Voice and AI-Driven Healthcare – Guest Article by Rare Patient Voice

- 22/01/2026

Volv Global at the Digital Lounge @Davos 2026

- 12/01/2026

MASH/NASH: Why Therapeutic Breakthroughs Demand a New Era of Patient Identification

- 05/12/2025

Bridging gaps across the CLL care pathway – Part 2: Knowing When To Treat

- 20/11/2025

Bridging gaps across the CLL care pathway – Part 1: From Signal to Stratification

- 04/11/2025

PCMG AI Symposium 2025: Cutting Through the Hype – Real Value vs. Overpromised Innovation

- 03/11/2025

Beyond the Hype: Volv Global CEO Christopher Rudolf at Frontiers Health 2025

- 02/11/2025

Cracking the Multiple Myeloma Code: Why Systemic Change is Needed to Match Therapeutic Breakthroughs

- 21/10/2025

Where Technology Meets Human: A Call to Unite Clinical Expertise and Real‑World Patient Voices

- 20/10/2025

Case Studies
Challenges
Diseases
Guest Article
Guest Post
Insights
Services
Stakeholder

Back
Clinical Development
Value & Access HEOR
Medical Affairs
Commercial Excellence

Back
Finding Patients
Earlier Detection
Predicting patient outcomes
Stratifying patient cohorts

Back
News
Events

Back
inFlow
inAdvance
inSight

Back
Oncology
Liver Disease

Rare Patient Voice guest post on Volv Global

The Patient Voice and AI-Driven Healthcare – Guest Article by Rare Patient Voice

-22/01/2026

Volv Global at the Digital Lounge @Davos 2026

Volv Global at the Digital Lounge @Davos 2026

-12/01/2026

MASH/NASH: Why Therapeutic Breakthroughs Demand a New Era of Patient Identification

MASH/NASH: Why Therapeutic Breakthroughs Demand a New Era of Patient Identification

-05/12/2025

Bridging gaps across the CLL care pathway – Part 2: Knowing When To Treat ... – AI for Transformation, Infection Risk, and Adaptive CLL Care

Bridging gaps across the CLL care pathway – Part 2: Knowing When To Treat

-20/11/2025

Bridging gaps across the CLL care pathway – Part 1: From Signal to Stratification ... Reimagining Early CLL Care through Algorithmic Insight

Bridging gaps across the CLL care pathway – Part 1: From Signal to Stratification

-04/11/2025

PCMG AI Symposium 2025: Cutting Through the Hype – Real Value vs. Overpromised Innovation

PCMG AI Symposium 2025: Cutting Through the Hype – Real Value vs. Overpromised Innovation

-03/11/2025

Beyond the Hype: Volv Global CEO Christopher Rudolf at Frontiers Health 2025

Beyond the Hype: Volv Global CEO Christopher Rudolf at Frontiers Health 2025

-02/11/2025

Cracking the Multiple Myeloma Code: Why Systemic Change is Needed to Match Therapeutic Breakthroughs

Cracking the Multiple Myeloma Code: Why Systemic Change is Needed to Match Therapeutic Breakthroughs

-21/10/2025

Where Technology Meets Human: A Call to Unite Clinical Expertise and Real‑World Patient Voices

Where Technology Meets Human: A Call to Unite Clinical Expertise and Real‑World Patient Voices

-20/10/2025

End of Content.